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Abstract
The Western Diet is typically high in saturated fats (SF) or omega-6 polyunsaturated fatty
acids (O6FA) with insufficient amounts of omega-3 polyunsaturated fatty acids (O3FA).
When chronic, this diet has been associated with an increased risk of respiratory
diseases. PURPOSE: To examine the effect of varying the fatty acid composition of an
acute High-Fat Meal (HFM) on postprandial airway inflammation. METHODS: Fifteen
individuals [6 M, 9 F; body mass index (BMI) = 25.3 ± 6.6 kg/m2] consumed three HFM
smoothies separated by at least 48 hours. The three smoothies were high in SF, O6FA, and
O3FA and were standardized to 12 kcal/kg body weight, 63% total fat, and 0.72 g/kg sugar.
Airway inflammation was measured using exhaled nitric oxide (eNO), airway function was
measured using pulmonary function tests, airway resistance was measured using impulse
oscillometry (iOS), and blood triglycerides (TG) and glucose were collected at baseline,
2h and 4h postprandially. RESULTS: There was no difference in eNO across time in any
condition or between conditions (p>0.05). FEV1 was increased from baseline to 2h
postprandially in the O6FA (p=0.038) and SF-HFM (p <0.001). O6FA was 2.7% higher
O6FA compared to that of SF at 4h postprandially (p=0.04). TG increased from baseline
to 2h in all conditions (p<0.001) and continued to trend upwards in the SF-HFM and toward
baseline in the PUFA HFMs. CONCLUSION: An acute HFM did not elicit an airway
inflammatory response for any condition. Different fatty acid compositions do not appear
to impact eNO during the postprandial period.
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Chapter I
The effect of varying fatty acid composition in a High-Fat Meal and its impact on
postprandial airway inflammation
Westernized Diet
Poor dietary habits have a significant role in increasing the risk of lifestyle related
diseases (1–3). Specifically, the Westernized diet is characterized as being nutrient-poor
and calorically dense with high levels of saturated fats or omega-6 polyunsaturated fatty
acids (O6FA) with insufficient amounts of omega-3 polyunsaturated fatty acids (O3FA).
In addition, Westernized Meals typically consists of excess red and processed meats, dairy
products, and refined carbohydrates with an inadequate intake of fish, fruits, vegetables,
and whole grains. Specifically, the Western diet is deficient in the amount of O3FA with a
current ratio of 20:1 O6FA to O3FA (4). It is important to note that O3FA and O6FA are
essential fatty acids and are important for normal proper physiological processes, appetite,
and metabolism (5). However, when meals are high in saturated fats or disproportionate in
the amount of O6FA to O3FA, this leads to an increased risk of obesity, cardiovascular,
metabolic, and respiratory diseases when consumed chronically (6, 7).
Saturated Fat High-Fat Meal and Airway Inflammation
Literature has suggested that meals high in saturated fat can lead to an increase in
exhaled nitric oxide (eNO), a validated measure of airway inflammation (8–13).
Specifically, Rosenkranz, et al. found that a 80% of subjects experienced an average of
19% increase in eNO following a HFM, who with no observed changes in overall
pulmonary function (8). Similarly, Ade and colleagues examined the effect of a HFM on
eNO in healthy adults either following 3-weeks of O3FA supplementation or placebo.
Their control group experienced an increase in eNO approximately 20% compared to the
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experimental group (14). While epidemiological research has shown an association
between dietary fat consumption and systemic and pulmonary inflammation, the
underlying mechanism linking the two remains unclear. It was originally proposed that the
increase in proinflammatory cytokines in systemic circulation mediated an inflammatory
response in the airway endothelium (15, 16). However, the observed time courses of airway
and systemic inflammation do not support this theory (8, 11, 12, 14, 17). A study by Kurti,
et al. found that 8-isoprostane, a marker of oxidative stress that is associated with asthma
development, increases systemically following a HFM but did not change in the airway
(18). Airway inflammation has been observed to peak at approximately 2 hours and return
towards baseline levels at 4 hours postprandially (8, 11, 12, 14, 17, 18). This suggests two
different mechanisms through which systemic and airway inflammation increase
postprandially. Despite the mechanisms uncertainty, it has been observed that chronic
levels of increased fat intake have been associated with increased airway inflammation,
which can lead to airway hyperresponsiveness and remodeling of the bronchial tubes,
characteristics of asthma (19–21).
The specific fat composition of a HFM is thought to alter the airway inflammation
response. Meals with high in polyunsaturated fatty acids (PUFAs), as opposed to meals
high in saturated fat, may have a less negative impact on health by either decreasing or
completely mitigating the eNO responses following an HFM, depending on the type of
PUFA. The proportion of O3FA:O6FA consumed is thought to play a role in the
inflammatory response during the postprandial period following a HFM, altering the
development of disease (4). Therefore, replacement of saturated fat with balanced
proportions of O3FA:O6FA in a HFM and in regular diet in general should decrease
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inflammation occurring postprandially, thereby decreasing the risk of chronic respiratory
disease.

O6 Polyunsaturated Fatty Acids and Inflammation
O6FA are essential PUFAs not naturally produced by the human body. O6FA
comes from animal-based food products including certain meats, flower oils, dairy
products, and eggs. When consumed in moderation, O6FA can be important for cell
membrane structure, assisting with blood pressure regulation, and inflammation. However
O6FA, when disproportionate with O3FA, can lead to an increased risk for obesity and
inflammatory diseases, such as asthma (4, 5, 22).
Linoleic acid is the most common PUFA in most western diets and can be
desaturated to other forms of O6FA such as arachidonic acid (23). Arachidonic acid is a
precursor to eicosanoids, specifically prostaglandins, thromboxanes, and leukotrienes and
are pro-inflammatory when derived through this pathway (24, 25). Specifically,
arachidonic acid upregulates the production of prostaglandin D2 (PGD2), thromboxane A2
(TXA2), and leukotriene B4 (LTB4) through the cyclooxygenase and lipoxygenase
pathways. When these mediators are present in high concentrations, they act to increase
bronchoconstriction (26), vasoconstriction, and vascular permeability and platelet
aggregation, respectively, (23, 27) while promoting airway inflammation. This initiates a
positive feedback loop, increasing bronchoconstriction (25). In addition, these
inflammatory mediators transcriptionally upregulate inducible nitric oxide synthase
(iNOS) to stimulate an increased release of nitric oxide, a potent bronchodilator, as a way
to reduce bronchoconstriction (28, 29). Nitric oxide originates in the airway epithelium due
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to an upregulation of iNOS and is observed through exhaled gas, making it a marker airway
inflammation (30). High concentrations of nitric oxide inhibit the production of iNOS in
the epithelial cells of the lungs until the amount of inflammation is reduced and then return
to baseline levels (29, 31). While the optimal ratio of O3FA:O6FA is yet to be determined,
intake of uneven concentrations of O6FA to O3FA leads to an increased production of
PGD2, TXA2, and LTB4 due to natural competition for the same enzymes. This elicits a
proinflammatory physiological state, with increases in vasoconstriction, platelet
aggregation, and bronchoconstriction (4, 28). If consumption of O6FA to O3FA is closer
to 1:1, O3FA has a higher affinity to be metabolized by the shared enzymes (24) which
allow the protective effects of O3FA to better counteract negative inflammatory effects of
O6FA than are shown when they are consumed in drastically uneven proportions.
O3 Polyunsaturated Fatty Acids and Inflammation
O3FAs, such as docosahexaenoic acid (DHA) and eicosapentaenoic (EPA), are also
essential PUFAs that must be consumed through diet. These are commonly found in fish
oils, seed oils, and certain plants. O3FA are anti-inflammatory and may reduce
bronchoconstriction in asthmatics (25) or mitigate the airway inflammatory response in
healthy adults leading to less bronchoconstriction to occur (14). O3FA counteract O6FA
through increased concentrations in PGI3 which stimulates vasodilation and inhibits
platelet activation; TXA3, a weak platelet aggregator; and LTB5, a weak inflammation
inducer (27). Recent literature also suggests that O3FA upregulate protective lipid
mediators, such as protectins, resolvins, and maresins and downregulate other
proinflammatory cytokines such as interleukins 1 and 6 (IL-1 and IL-6) (32–36). The
attenuation in inflammatory markers further decreases concentrations of platelet activated
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factors and PG mediators resulting in decreased iNOS release from airway endothelial cells
(37, 38). These reactions decrease the amount of proinflammatory activity following a
HFM, minimizing the amount of bronchoconstriction, resulting in a reduced amount of
eNO.
Long-term dietary consumption relatively high in O3FA can lead to decreases in
inflammatory markers related to cardiovascular disease (33), metabolic syndrome (39), and
risk of obesity (5), while also impacting pulmonary function (40). Dietary fatty acid
composition, specifically when high in O3FA, has been shown to decrease asthma
prevalence (41). In a meta-analysis by Yang et al., fish intake or dietary supplementation
with O3FA was inversely associated with asthma incidence in children, however no
significant association was found in adults (41). However, Li et al. followed participants
of the CARDIA study for 20 years and found that higher intake of O3FA was inversely
associated with asthma incidence in adults (42).
Further research on the effect of increasing O3FA consumption on airway
inflammation and as a treatment for asthma has been investigated. Ade, et al. found that
the eNO response was mitigated during the postprandial period following a HFM in
subjects who had undergone a 3-week O3FA supplementation when compared to a group
who received a placebo supplement, despite postprandial serum triglyceride levels between
both groups being similar at pre- and post-HFM (14). Emelyanov, et al. reported decreased
daytime wheezing and airway inflammation in steroid-native atopic asthmatics following
8-weeks of O3FA supplementation (43). Research on the short- and long-term effects of
O3FA supplementation largely suggest that increasing O3FA dietary intake can lead to
profound health benefits.
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Prior research on the effect that a single HFM has on airway inflammation have
used meals that were high in saturated or Trans fatty acids. Moreover, literature
surrounding the topic of a more balanced O6FA to O3FA ratio or higher O3FA intake has
been conducted using prolonged dietary intervention with O3FA supplementation. No
investigations have been done examining the effect of an acute HFM that is high in O3FA
or O6FA on airway inflammation. Therefore, the purpose of this study is to determine
whether varying a meal to be high O3FA or O6FA in an acute HFM will alter the airway
inflammation response when compared to a meal high in saturated fat. We hypothesize that
the airway inflammatory responses following the PUFA HFMs will be less than that
following the typical Westernized meal that is high in saturated fats. Additionally, we
predict that an the HFM high in O3FA will have an attenuated eNO response when
compared to a meal high in O6FA.

Definition of terms
Postprandial period: 4h period immediately following consumption of a HFM
High fat meal: 12 kcal/kg body weight; 63% calories from fat, 0.72 g/kg body weight sugar
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Chapter II
Methodology
Participants
Participants will be recruited using posted fliers and word-of-mouth from the James
Madison University community and surrounding Harrisonburg-Rockingham area. Fifteen
healthy young adults between the ages of 18-35 years will be recruited for this study.
Healthy will be defined as without any cardiovascular, metabolic, or respiratory disease
diagnosis and not currently taking medications that could affect airway inflammation,
blood lipids, or glucose.
Experimental Design
This study will utilize a double-blind randomized crossover experimental design.
Participants will be asked to come to the lab on four occasions: the initial visit and three
separate HFM sessions. At the initial session, informed consent will be attained. Following
consent of participation, familiarization and baseline sampling including pulmonary
function tests, exhaled gases and anthropometric measurements will occur. Finally, the
procedures for a Food Intake Record consisting of three weekdays and one weekend day
will be explained. All Food Intake Records will be analyzed using the Nutrition Data
System for Research (NDSR, Minneapolis, MN) and reviewed for quality assurance.
In the subsequent three visits, participants will complete each high-fat meal (HFM)
condition, in a randomized order, separated by at least 48 hours. Prior to each condition,
they will be asked to abstain from exercise for the 48 hours leading into each meeting.
Upon arrival to their first HFM condition, participants will return their 4-day Food Intake
Record. They will be asked to replicate their diet from the 24-hours leading into their first
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session, for their final two subsequent sessions. This replication will be recorded using a
24-hour Food Intake Record and reviewed prior to the start of each HFM session to ensure
compliance and accuracy. Blood lipids, glucose, airway inflammation, and pulmonary
function will be assessed at baseline (0), 2, and 4 hours postprandially. Following the final
session, participants will be asked to wear a tri-axial Actigraph GTX3+ accelerometer
(Actigraph, LLC, Pensacola, FL) for seven consecutive days and complete an international
physical activity questionnaire (IPAQ) to assess habitual physical activity level.
HFM Composition
All participants will complete each of the three HFM challenges. For each testing
session, participants will be asked to arrive at the lab following a 10-hour fast. Each meal
challenge will be a smoothie, standardized to 12 kcal/kg body weight and 0.72 g/kg body
weight sugar. Each meal will consist of a total fat content of 63% fat. Fat composition will
vary as follows: saturated fat meal (SF-HFM) will contain <0.02% fat from O6FA and
O3FA; the high O6FA HFM (O6FA-HFM) will have a ratio of 15:1 O6FA:O3FA with
0.11 g/kg body weight of saturated fat; the high O3FA HFM (O3FA-HFM) will have a
ratio of 15:1 O3FA:O6FA and contain 0.11 g/kg body weight saturated fat. Smoothie
randomization procedure will be done using a random number generator to select which
fatty acid composition to go with each flavor (blueberry, strawberry, or peach). The order
in which subjects will receive each condition will also be randomized using the same
approach. Each smoothie will be made by a Registered Dietitian, not participating in testing
protocols, from the James Madison University Department of Health Professions.
Smoothies will be standardized and made within 3 days prior to each session and brought
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to the James Madison University Human Performance Lab in Godwin Hall to ensure
researchers are blinded to the condition of each trial.
HFM Testing Protocol
At each high-fat smoothie session, at baseline, 2- and 4- hours postprandially, eNO,
blood lipids, blood glucose, and pulmonary function tests will be measured. Following
baseline measurements, the smoothie will be consumed within a 20 minutes period, with
time for the postprandial period beginning upon completion of the smoothie. To control for
minimal physical activity, all participants will be asked to either remain in the lab for the
duration of the session or walk solely to lecture classes within Godwin Hall during the
four-hour study period.
Blood Analyses
Blood lipids and glucose will be obtained using a finger stick to collect the blood
and analyzed with a CardioChek Plus Analyzer (PTS Diagnostics, Indianapolis, IN). Each
blood glucose measure will require a 5 microliter (µL) blood sample and blood lipids
require a 40 µL sample. These measures will be used to assess metabolic responses to each
HFM condition.
Exhaled Gases
During each session, airway inflammation will be assessed using a Niox Vero
(Circassia AB, Morrisville, NC). This equipment measures eNO and is an easy to
understand, noninvasive way to assess airway inflammation. This test requires participants
to exhale for approximately 6-10 seconds at a steady rate into the mouthpiece of the eNO
analyzer. These tests will be performed according to ATS/ERS guidelines for eNO
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assessment (44). At each time point, eNO assessment will be completed twice, then
averaged.
Pulmonary Function Tests
Pulmonary function will be assessed using maximum flow-volume loops using
Vmax Encore metabolic cart (Vyaire Medical, Mettawa, IL). These tests will be performed
according to ATS/ERS guidelines for pulmonary function testing (45). Participants will be
asked to wear a nose clip and then maximally inhale, forcibly exhale for approximately 6
seconds, then maximally inhale once more into a spirometer to complete the assessment.
This will determine each participant’s forced expiratory volume in 1-second (FEV1),
forced vital capacity (FVC), forced expiratory flow between 25% and 75% of forced vital
capacity ((FEF25-75% of FVC)), and peak expiratory flow (PEF). Measurements will be
repeated until three measurements are within a 10% range; these values will be averaged
and used for analyses.
Airway resistance will be measured using impulse oscillometry system (iOS) also
using Vmax Encore metabolic cart (Vyaire Medical, Mettawa, IL). This method requires
participants to wear a nose clip and breathe normally on a mouthpiece while the machine
sends repeated bursts of air into the subject's mouth, allowing assessment of resistance in
the central and peripheral airways. Three measurements within 20% will be averaged and
used for analyses.
Anthropometric Measurements
During the initial session, height will be measured with a stadiometer (Charder Model
HM 200P, Charder Electronic Co Ltd., Taichung, Taiwan) and weight with a standard
physician’s scale (Dymo Pelouze model 4040, Newell Brands, Hoboken, NJ). Body
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composition will be assessed during the initial visit for each participant via dual x-ray
absorptiometry (DEXA) using GE Lunar iDXA (Fairfield, CT). Participants will be asked
to wear comfortable clothing and remove all metal (i.e. jewelry, sweatshirts with zippers,
shoes, etc.) and lie supine in the center of the table for approximately 10 minutes while the
scan occurs. Waist circumference will also be measured using Gulick tape measurer
(Creative Health Products, Ann Arbor, MI) at the narrowest part of the waist.
Statistical Analyses
The data will be analyzed for airway inflammation, PFTs, iOS, and blood lipids and
glucose using a repeated measures ANOVAs assessing time (hour) by condition (one of
the three smoothie conditions). Post hoc testing with a Bonferroni correction will be used
if any of the ANOVAs run result in statistical changes. Additional exploratory analyses
will be done to determine whether lifestyle factors, such as habitual physical activity or
habitual dietary intake, are associated with changes in airway inflammation measures
during the postprandial period following a HFM.
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Abstract
The Western Diet is typically high in saturated fats (SF) or omega-6 polyunsaturated fatty
acids (O6FA) with insufficient amounts of omega-3 polyunsaturated fatty acids (O3FA).
When chronic, this diet has been associated with an increased risk of respiratory
diseases. PURPOSE: To examine the effect of varying the fatty acid composition of an
acute High-Fat Meal (HFM) on postprandial airway inflammation. METHODS: Fifteen
individuals [6 M, 9 F; body mass index (BMI) = 25.3 ± 6.6 kg/m2] consumed three HFM
smoothies separated by at least 48 hours. The three smoothies were high in SF, O6FA, and
O3FA and were standardized to 12 kcal/kg body weight, 63% total fat, and 0.72 g/kg sugar.
Airway inflammation was measured using exhaled nitric oxide (eNO), airway function was
measured using pulmonary function tests, airway resistance was measured using impulse
oscillometry (iOS), and blood triglycerides (TG) and glucose were collected at baseline,
2h and 4h postprandially. RESULTS: There was no difference in eNO across time in any
condition or between conditions (p>0.05). FEV1 was increased from baseline to 2h
postprandially in the O6FA (p=0.038) and SF-HFM (p <0.001). O6FA was 2.7% higher
O6FA compared to that of SF at 4h postprandially (p=0.04). TG increased from baseline
to 2h in all conditions (p<0.001) and continued to trend upwards in the SF-HFM and toward
baseline in the PUFA HFMs. CONCLUSION: An acute HFM did not elicit an airway
inflammatory response for any condition. Different fatty acid compositions do not appear
to impact eNO during the postprandial period.
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Introduction
The Western Diet is characterized by being energy-dense and nutrient-poor (46).
When specifically examining fat intake, excess amounts of saturated and omega-6 fatty
acids (O6FA) and insufficient amounts of omega-3 (O3FA) are common, resulting in an
average O6FA:O3FA ratio of 20:1 (2). While the specifically recommended ratio of O6FA:
O3FA has yet to be defined, evidence suggests that lowering the ratio closer to 1:1 could
be beneficial for health (4, 21). When a diet with a high O6FA: O3FA ratio is consumed
chronically, the imbalance in fatty acids has been associated with an increased risk of
cardiovascular, metabolic, and respiratory diseases (6,7). Meals high in fat have also
demonstrated increases in exhaled nitric oxide (eNO), a validated measure of airway
inflammation (8-13), however, how the specific type and proportion of fat in a high-fat
meal (HFM) may alter the airway inflammatory response remains to be elucidated.
Rosenkranz, et al. found that 80% of subjects experienced an average increase in eNO by
19% following an acute HFM that was composed primarily of saturated fat (8). While this
acute HFM transiently increased airway inflammation, there were no corresponding
decreases in pulmonary function through the maximal flow-volume loop (MFVL) which
is the gold standard to assess pulmonary function. However, chronic postprandial airway
inflammation has been shown to increase airway hyperresponsiveness and remodeling of
the bronchial tubes, which are characteristics of asthma (18-20). Acute inflammation can
become chronic, thus by limiting the amount of exposure to acute airway inflammation
long term risk of damage to the airways is reduced.
O3FA has long been recognized to have anti-inflammatory properties (5, 18, 47).
In the airways specifically, subjects who consumed O3FA supplementation for three weeks
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exhibited an attenuated eNO response after an acute HFM challenge compared to a control
group without O3FA supplementation (14). However, the benefits of O3FA can be
diminished by the excess intake of O6FA commonly found in the Westernized Diet (4, 18).
While O3FA and O6FA are both essential polyunsaturated fatty acids (PUFAs), they are
desaturated using the same enzymes and can create a more or less inflamed physiological
state depending on whether O6FA or O3FA is metabolized. Over time, the metabolism of
O3FA or O6FA can result in different impacts on both systemic and airway inflammation
following a HFM (4, 5). When O6FA is consumed at much higher proportions to O3FA
chronically, this can lead to an increased risk for obesity and inflammatory diseases, such
as asthma (4, 5, 21).
Despite the understanding that the ratio of O6FA to O3FA can have a significant
impact on the inflammatory state, little research has examined the airway response to an
acute HFM that is high in O3FA or O6FA. The majority of current research on single HFM
includes meals that are high in saturated fat (8, 10, 11, 12, 14). Therefore, the purpose of
this study is to determine whether varying the ratio of O3FA vs O6FA in an acute HFM
will alter the airway inflammatory response when compared to a meal high in saturated fat.
We hypothesize that the airway inflammatory responses following the PUFA HFMs will
be less than that following the typical Westernized Diet that is high in saturated fats.
Additionally, we predict that the HFM high in O3FA will have an attenuated eNO response
when compared to the meal high in O6FA.
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Methodology
Participants
Participants were recruited using word-of-mouth from the James Madison
University community. Fifteen healthy young adults (6 male, 9 female; ages 21.9 ± 1.5
years) were recruited. All subjects were free of any cardiovascular, metabolic, or
respiratory disease diagnosis and were not taking medications that could affect airway
inflammation, blood lipids, or glucose. All subjects were asked to discontinue any
supplementation with ergogenic aids. The habitual diet was assessed using a 4-day Food
Intake Record which was completed following the initial visit and returned at the first HFM
session. All Food Intake Records were analyzed using the Nutrition Data System for
Research (NDSR, Minneapolis, MN) and reviewed for quality assurance. Habitual PA was
assessed via tri-axial Actigraph GTX3+ accelerometer (Actigraph, LLC, Pensacola, FL)
worn for seven consecutive days following the final HFM session. Subjects were also
asked to complete the International Physical Activity Questionnaire (IPAQ) to assess
habitual physical activity level.
Experimental Design
This study utilized a double-blind randomized crossover experimental design.
Participants were asked to come to the lab on four occasions: the initial visit and three
separate HFM sessions.
At the initial session, informed consent was performed followed by familiarization
and baseline sampling of pulmonary function tests, exhaled gases, and anthropometric
measurements.
HFM Session Protocol
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In the subsequent three visits, participants completed each HFM condition, in a
randomized order, each separated by at least 48 hours. Conditions were randomized using
a random number generator. Prior to each condition, they were asked to abstain from
exercise for 48 hours and fast for at least 10-hours. At the first HFM condition, participants
returned their 4-day Food Intake Record. Before each subsequent HFM session,
participants replicated their diet for the 24-hours before their first session. This replication
was recorded using a 24-hour Food Intake Record and reviewed prior to the start of each
HFM session to ensure compliance. Airway inflammation, pulmonary function, and blood
glucose and lipids were assessed at baseline (0), as well as 2 and 4 hours postprandially
(Figure 1). Following baseline assessment, the smoothie was consumed within 20-minutes.
The postprandial timeline began immediately upon completion of the smoothie. To control
for minimal physical activity, all participants had to remain in the lab for the duration of
the session or walk solely to lecture classes within Godwin Hall during the 4-hour study
period.
HFM Composition
Each HFM condition was associated with a particular flavor of smoothie
(strawberry, peach, or blueberry) and was standardized to 12 kcal/kg body weight, 0.72
g/kg body weight sugar, and 63% total fat (Table 1). Each smoothie was made within 3
days prior to each session by a Registered Dietitian Nutritionist from the James Madison
University Department of Health Professions who did not participate in testing protocols,
ensuring researchers and participants were blind to each condition.
Airway Inflammation
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During each session, airway inflammation was assessed using a Niox Vero
(Circassia AB, Morrisville, NC). Testing was performed according to ATS/ERS guidelines
for eNO assessment (43). Subjects were seated in the same upright in the posture for every
assessment with feet flat on the floor without a nose clip. Subjects were asked to inhale to
maximum capacity then exhale at a constant flow rate for 6 seconds. At each time point,
eNO assessment was completed twice, then averaged.
Pulmonary Function Tests
Pulmonary function was assessed using the MFVL on a Vmax Encore metabolic
cart (Vyaire Medical, Mettawa, IL). These tests were performed according to ATS/ERS
guidelines for pulmonary function testing (44). This test was used to determine each
participant’s forced expiratory volume in 1-second (FEV1), forced vital capacity (FVC),
forced expiratory flow between 25% and 75% of forced vital capacity ((FEF25-75% of
FVC)), and peak expiratory flow (PEF). This test was repeated until three measurements
within 10% of each other were obtained; these three values were averaged and used for
analyses.
Airway resistance was measured using the impulse oscillometry system (iOS) on
the Vmax Encore metabolic cart (Vyaire Medical, Mettawa, IL). Subjects were seated
upright with their feet flat, neck slightly extended, a noseclip on, and mouth covering a
mouthpiece with a tongue depressor. The same posture was performed for each test.
Subjects were instructed to keep their cheeks hollow and breathe normally for
approximately 20 seconds as resistance and reactance were measured. Three measurements
within 20% were averaged and used for analyses.
Blood Analyses
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Blood lipids and glucose were obtained using a finger stick to collect the blood and
analyzed with a CardioChek Plus Analyzer (PTS Diagnostics, Indianapolis, IN). Each
blood glucose measure required 15 microliters (µL) and blood lipids required a 40 µL blood
sample. These measures were used to assess metabolic responses to each HFM condition.
Anthropometric Measurements
During the initial session, height was measured with a stadiometer (Charder Model
HM 200P, Charder Electronic Co Ltd., Taichung, Taiwan) and weight with a standard
physician’s scale (Dymo Pelouze model 4040, Newell Brands, Hoboken, NJ). Waist
circumference was measured and body composition was assessed via dual x-ray
absorptiometry (DEXA) using GE Lunar iDXA (Fairfield, CT).
Statistical Analyses
Data was first checked for normality and adjusted if baseline measurements were
not normally distributed. The data was analyzed for airway inflammation, blood lipids, and
blood glucose using a repeated measures ANOVA assessing time (3 time points) by
condition (3 conditions) using IBM SPSS Statistics v26.0 (IBM Corporation, Armonk,
NY). Post hoc tests utilized a LSD correction. Significance for all analyses was set a priori
to p<0.05.
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Results
Subject Characteristics
Fifteen college-aged participants (21.9 ± 1.5 years old; 6 M/ 9F) successfully
completed the study. Subject characteristics are presented in Table 2. The only difference
between sexes was mean body fat percentage (males: 18.4 ± 6.8%; females: 30.8 ± 10.3%;
p=0.022). The average time spent in moderate to vigorous physical activity (MVPA) per
week for all participants was 6.6 ± 2.7 hours with a range of 3.5-10.3 hours per week. The
nutritional information for each HFM condition is presented in Table 2.
Airway Inflammation
There was no time by condition interaction, nor main effects for time or condition
for eNO (p>0.05; Figure 2).
Pulmonary Function Data
There was no significant time by condition effect for any of the iOS airway
resistance data (p>0.05, Table 3). There was a significant time by condition interaction in
the FEV1 for the O6-HFM and SF-HFM (p=0.019, Table 4). FEV1 significantly increased
in the O6FA-HFM (p=0.038) and in the SF-HFM (p<0.001). There was a significant
difference in FEV1 between the O6FA-HFM and SF-HFM at 4h (p=0.04) where it was
2.7% higher in O6FA-HFM compared to SF-HFM.
Biochemical Data
Mean cholesterol, high density lipoproteins (HDL), and calculated low density
lipoproteins (LDL) are presented in Table 5. There was a significant time by condition
interaction for calculated LDL (p=0.007). The time by condition effect for cholesterol
approached significance (p=0.054).
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There was a significant main effect of time for the SF, O6FA, and O3FA-HFM in
triglycerides (p0.001; Figure 3). From baseline to 2h triglycerides increased 25.7% in the
SF-HFM, 30.4% in the O6FA-HFM, and 30.5% in the O3FA-HFM (p<0.001 for all
conditions). From 2 to 4h postprandially, the triglyceride concentrations were significantly
lower in the O6FA and O3FA HFM (p=0.02 and 0.016, respectively) decreasing 22.9 and
16.6%, respectively. Triglycerides trended upwards throughout the duration of the study
for the SF-HFM increasing 25.8% from baseline to 2h baseline (p<0.001) and remaining
31.1% higher than baseline at 4h (p<0.001). There was no significant difference between
condition at any time point (p>0.05).
When examining glucose, there was a significant effect of condition (p=0.0048)
and time (p<0.001; Figure 4). At 2h postprandially glucose was significantly higher in the
PUFAs meals than the saturated HFM (P=0.049). There was a significant main effect of
time in the high O6FA and O3FA HFMs (p=0.001 and 0.004, respectively) from baseline
to 4h and from 2h to 4h postprandially. At 4h postprandially, plasma glucose levels were
significantly lower than baseline for the high O6FA (p=0.001) and O3FA HFMs (p=0.006).
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Discussion
Major findings
The present study aimed to examine the effect of varying the fatty acid composition
in an acute HFM on airway inflammation. To our knowledge, no studies have been
performed examining these effects. We hypothesized that (1) both PUFA HFMs would
result in a lower airway inflammatory response compared to that of the SF-HFM and (2)
that the O3FA-HFM would result in a further attenuated eNO response compared to that
of the O6FA-HFM. Our results do not support these hypotheses; eNO did not differ across
condition or time points, indicating that the HFMs in the present study failed to create an
airway inflammatory response, regardless of the fatty acid composition. These findings
also do not support previous research regarding the effect of a HFM on postprandial airway
inflammation (8, 11, 12, 14).
SF-HFM and Airway inflammation
Prior literature has indicated that meals high in saturated fat have consistently led
to increases in postprandial airway inflammation (8, 10-12, 14). However, the precise
mechanism remains unclear, as the time-courses of airway and systemic inflammation do
not support original theories that systemically-circulated proinflammatory cytokines
mediated the airway inflammatory response (17). The present study failed to observe any
increase in airway inflammation after the SF-HFM, which could potentially be due to a
lower amount of saturated fat in SF-HFM. Previous studies used a SF-HFM composition
that contained 1 g of fat per kilogram of body weight with 4.5 g per serving coming from
saturated fat whereas the present study used slightly less (0.82 g/kg body weight total fat,
0.5 g/kg saturated fat) than that amount (8, 12, 14). This could suggest a threshold effect
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of the amount of saturated fat needed to see a response in eNO and should be considered
for future research. Additionally, although Rosenkranz did find statistical increases in eNO,
the average increases were relatively small (mean change = 3.3 ppb) and were unlikely to
be clinically significant (8). Furthermore, the equipment used to assess eNO differed
between previously conducted research and the present study, which is another possible
explanation for the discrepancy (8, 11, 12, 14).
O6FA and Airway Inflammation
The present study did not find any changes in eNO in response to the O6FA-HFM.
Although research has shown an effect of chronic exposure to elevated O6FA, there is little
to no research on the acute effects of an O6FA-HFM on airway inflammation. The lack of
an increase in postprandial eNO following an O6FA-HFM in the present study could be
due to the type of O6FA used in the HFM, linoleic acid (LA). LA is the most common
O6FA in the Western diet and can be desaturated into other forms of O6FA, most often
into arachidonic acid (AA) (22). AA upregulates proinflammatory eicosanoids (22-24) that
lead to increased bronchoconstriction (25), vasoconstriction, vascular permeability and
platelet aggregation (22, 26) which in turn promote airway inflammation. In a systematic
review by Rett and Whelan, it was determined that neither increasing nor decreasing LA
intake in adults consuming a Western Diet had an effect on the amount of AA concentration
in plasma phospholipids and thus, did not impact the production of the aforementioned proinflammatory mediators (48). This is likely due to the already large amount of LA
consumed in the Western Diet, oversaturating the LA to AA pathways. Therefore, it is
possible that the present study did not see a change in postprandial eNO due to the subject
LA to AA pathway already having been oversaturated with no potential to increase the
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negative effect of high O6FA on airway inflammation. The present study also utilized
whole meals that included fruit, which led to a moderate antioxidant content. Research by
Tenero et al. found that 4 weeks of antioxidant supplementation in children with asthma
significantly decreased eNO levels (from 14 ppb to 11 ppb) (49). This could have resulted
in an inhibition of oxidation and could result in a decreased amount of postprandial airway
inflammation. While the acute effect of antioxidant consumption on airway inflammation
has yet to be determined, this suggests a potential protective effect of antioxidants on the
airways.

O3FA and Airway Inflammation
Previous literature has indicated an attenuation of airway inflammation following
short or long-term O3FA supplementation (14, 42). In the current study, there was no
significant difference in the postprandial eNO responses between the O3FA-HFM and
either O6FA-HFM and SF-HFM. Therefore, at the doses used in this study, it appears that
there is no protective effect of an acute dose of O3FA in preventing airway inflammation.
This is the first study, to the authors’ knowledge, to examine the acute impact of
high O3FA consumption on airway inflammation. The present study utilized a meal with
whole food to mimic a more true-to-life situation and found no significant effect on
postprandial eNO. Long-term experimental studies have indicated a protective effect
following the supplementation of O3FA (14, 42, 50). For example, Emelyanov et al. found
expired hydrogen peroxide levels, another marker of airway inflammation, to be
significantly reduced in asthmatics following 8 weeks of O3FA supplementation (42). Ade
et al. examined the effect of 3-weeks of fish oil supplementation on eNO following a meal
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high in saturated fat in healthy, non-asthmatic subjects and reported eNO was unchanged
pre- to post-HFM while the control group still saw ~20% increase in postprandial eNO
(14). O3FA decrease the proinflammatory eicosanoids normally upregulated by O6FA
while also upregulating protective lipid mediators, which work to inhibit other
proinflammatory cytokines (31-35). This may lead to an attenuation in the airway
inflammatory response in healthy adults, resulting in a lower postprandial eNO response
(14). These mechanisms may still translate to an acute HFM, but would likely require meals
with higher levels of fat to detect significant differences.

Limitations
One potential limitation of the present study is that seasonal pollen increases
occurred during a portion of data collection. Airway epithelial cells are highly susceptible
to environmental allergens or respiratory infections and could result in an allergen-induced
airway inflammatory response, thus increasing eNO responses. However, in the present
study, eNO was closely monitored to ensure drastically abnormal reactions did not occur.
Moreover, if this had occurred, it would have resulted in an exacerbated eNO response,
resulting in significant changes between time points or conditions. Due to the lack of
contrasts over time or between conditions, it is unlikely that this had an effect. Additionally,
previous studies have examined differences in postprandial eNO using chemiluminescence
(8, 11, 12, 14). However, Niox analyzers have been found to have a high correlation with
chemiluminescence analyzers (0.972; 51) and had good sensitivity and specificity in
healthy subjects, therefore the eNO analyzer was unlikely the cause of the discrepancy
between previous literature and the results presented in this study. It is also important to
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note that it has yet to be determined how long it would take for O3FA or O6FA to produce
EPA, DHA, or AA. Therefore, it is possible that if the observed postprandial period were
longer, we may have seen an effect. However, HFM challenges that were high total fat and
SF have reported eNO peaked at 2h postprandially and trended back towards baseline at
4h postprandially thus validating the time course of the present study.
Conclusion
In summary, our findings indicated no increase in airway inflammation following
high fat meal with varying fatty acid compositions (i.e. SF, O6FA, and O3FA). Specific
meal composition could have played a role in the absence of airway inflammation after a
HFM. Future research should examine a HFM with higher fat content to fully understand
the impact of a HFM on postprandial airway inflammation and compare the effects of
supplementation versus true foods in the same experiment.
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IV. Appendicies

Table 1. Nutritional information for each HFM smoothie.

O3FA-HFM O6FA-HFM
Kcal (g/kg)
Total fat (g/kg)
Sat fat (g/kg)
Omega-6 (g/kg)
Omega-3 (g/kg)
Sugar (g/kg)
Sat Fat (% of Total Fat)
Omega-6 (% of Total Fat)
Omega-3 (% of Total Fat)
*Total Fat is 63% of total kcal.

12.01
0.83
0.11
0.05
0.4
1.02
14.07
6.61
48.11

12.02
0.83
0.11
0.2
0
0.98
1.31
23.33
<0.01

SF-HFM
12.1
0.82
0.5
0.02
0.01
1.02
61.28
0.02
0.02
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Table 2. Participant characteristics

Age (years)
Height (in)
Weight (kg)
Waist Circumference (cm)
Body Mass Index (kg/m2)
Body Fat (%)
Time in MVPA (hours/week)

N=15 (M=6, F=9)
Mean ± SD
21.9 ± 1.5
67.9 ± 3.7
74.7 ± 14
78.6 ± 10.4
25.3 ± 5.6
25.8 ± 10.8
6.6 ± 2.7
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Table 3. Impulse oscillometry system (iOS) data from baseline to 4h postprandially
following a HFM high in SF, O6FA, or O3FA.

R5

R20

X5

FRES

AX

Baseline
2h
4h
Baseline
2h
4h
Baseline
2h
4h
Baseline
2h
4h
Baseline
2h
4h

O3FA-HFM

O6FA-HFM

SF-HFM

2.9 ± 0.8
2.9 ± 0.8
2.9 ± 0.7

3.0 ± 0.8
2.9 ±0.8

p=0.892

2.7 ± 0.6
2.6 ± 0.5
2.7 ± 0.6

2.9 ± 0.8
2.8 ± 0.7
2.7 ±0.7
2.7 ± 0.6#

3.1 ± 0.8
3.0 ± 0.9
3.0 ± 0.9
2.8 ± 0.7
2.7 ± 0.6º
2.7 ± 0.7

p=0.506

-1.0 ± 0.3
-1.0 ± 0.2
-1.0 ± 0.2

-1.0 ± 0.3
-1.0 ± 0.3
-1.0 ± 0.3^

-1.0 ± 0.3
-1.0 ± 0.3
-1.0 ±0.3

p=0.640

12.5 ± 3.7
11.8 ± 4.8
12.4 ± 4.0

13.0 ± 4.7
11.3 ± 2.4
12.0 ± 3.1

13.4 ± 4.6
11.3 ± 4.1
12.1 ± 3.1

p=0.343

3.1 ± 1.9
3.2 ± 2.1
2.7 ± 1.3

3.4 ± 2.1
2.7 ± 1.4
2.9 ± 2.0

3.3 ± 2.2
3.1 ± 2.0
3.0 ± 1.9

p=0.293

R5: central airway resistance; R20: peripheral airway resistance; X5: amount of
resistance while breathing in at an impulse frequency of 5 Hz; FRES: resident frequency;
AX: area under the curve between 5Hz and Fres.
*indicates significance from baseline to 2h (p<0.05) ^indicates significance from 2h to 4h
(p<0.05) #indicates significance between baseline and 4h (p<0.05) ✚indicates significance
between O6FA and SF HFM (p<0.05) ☨indicates significance between O6FA and O3FA
HFM (p<0.05) ºindicates significance between O3FA and SF HFM (p<0.05)
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Table 4. Pulmonary function test (PFT) data from baseline to 4h postprandially following
a HFM high in SF, O6FA, or O3FA.
O3FA-HFM
O6FA-HFM
SF-HFM
FVC

Baseline
2h
4h

4.6 ± 1.1
4.6 ± 1.1
4.6 ± 1.1

FEV1

Baseline
2h
4h

3.7 ± 0.9
3.8 ± 0.9
3.8 ± 0.9

4.6 ± 1.1
4.5 ± 1.0
4.5 ± 1.0
3.6 ± 0.8
3.7 ± 0.8*
3.7 ± 0.8^#

FEV1/FVC

Baseline
2h
4h

81.4 ± 5.4
81.8 ± 4.5
82.4 ± 4.1

79.7 ± 7.0
82.1 ± 5.0*
82.8 ± 4.8#

3.7 ± 0.8
3.7 ± 0.9*
3.6 ± 0.8✚
81.8 ± 4.5
83.0 ± 4.7*
83.2 ± 4.5#

FEF25-75%

Baseline
2h
4h

3.8 ± 1.1
3.9 ± 1.0
3.9 ± 1.0

3.6 ± 1.0
3.9 ± 1.0*
4.0 ± 1.0#

3.7 ± 0.9
3.9 ± 1.0*
3.9 ± 1.0

Baseline

7.6 ± 1.9
7.5 ± 1.9

7.2 ± 1.8
7.6 ± 1.9*

7.6 ± 1.8
7.5 ± 1.6

7.7 ± 2.0

7.6 ± 1.7#

7.7 ± 2.0

PEF

2h
4h

4.5 ± 1.0
4.5 ± 1.0
4.4 ± 1.0

FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; FEV1/FVC (%): ratio
of forced expiratory volume in 1 s to forced vital capacity; FEF25-75%: forced expiratory
flow between 25 and 75%; PEF: peak expiratory flow.
*indicates significance from baseline to 2h (p<0.05) ^indicates significance from 2h to 4h
(p<0.05) #indicates significance between baseline and 4h (p<0.05) ✚indicates significance
between O6FA and SF HFM (p<0.05) ☨indicates significance between O6FA and O3FA
HFM (p<0.05) ºindicates significance between O3FA and SF HFM (p<0.05)

p=0.498

p=0.019

p=0.218

p= 0.078

p=0.381
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Table 5. Metabolic markers from baseline to 4h postprandially following HFM either high
in O3FA, O6FA, or saturated fat.
O3FA-HFM
O6FA-HFM
SF-HFM
141 ± 23.1
139.8 ± 21.9
141.5 ± 21.1

151.9 ± 23.7
146.6 ± 24.2
153.5 ± 27.8

143 ± 23.2
144.7 ± 22.4
145.7 ± 22.7

51.7 ± 7.1
51.6 ± 8.1
51.9 ± 8.4

51.9 ± 8.4
52.6 ± 9.7
51.9 ± 11.1

53 ± 9.4
52.3 ± 11.4
52.3 ± 9.2

p=0.185

HDL

Baseline
2h
4h

71 ± 20.3
62.1 ± 19.1*
67.1 ± 17.0

80.4 ± 18.9
63.1 ± 21.8*
77.8 ± 23.6^

71.7 ± 16.3
67.7 ± 17
66.9 ± 18.7

p=0.007

Calculated LDL

Baseline
2h
4h

Cholesterol

Baseline
2h
4h

p=0.054

*indicates significance from baseline to 2h (p<0.05) ^indicates significance from 2h to 4h
(p<0.05) #indicates significance between baseline and 4h (p<0.05) ✚indicates significance
between O6FA and SF HFM (p<0.05) ☨indicates significance between O6FA and O3FA
HFM (p<0.05) ºindicates significance between O3FA and SF HFM (p<0.05)
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Figure 1. The HFM session protocol. Time increments are listed in minutes. Exhaled nitric
oxide is listed as eNO. Impulse oscillometery system is listed as iOS. Pulmonary function
tests are listed as PFTs.
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Figure 2. Exhaled nitric oxide (eNO) from baseline to 4h postprandially following meals
high in O3FA, O6FA, or saturated fat.
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Figure 3. Mean plasma triglyceride response from baseline to 4h postprandially
following consumption of HFM either high in O3FA, O6FA, or saturated fat.
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*indicates significance from baseline to 2h (p<0.05) ^indicates significance from 2h to 4h
(p<0.05) #indicates significance between baseline and 4h (p<0.05)
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Figure 4. Mean plasma glucose response from baseline to 4h postprandially following
consumption of HFM that was high in O3FA, O6FA, or saturated fat.
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*indicates significance from baseline to 2h (p<0.05) ^indicates significance from 2h to 4h
(p<0.05) #indicates significance between baseline and 4h (p<0.05) ✚indicates significance
between O6FA and SF HFM (p<0.05) ☨indicates significance between O6FA and O3FA
HFM (p<0.05) ºindicates significance between O3FA and SF HFM (p<0.05)
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Project Title: Does Varying the Fatty Acid Composition of a High-Fat Meal Impact Post-Prandial Airway
Inflammation, Lipemia, and Glycemia?
Consent to Participate in Research
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Drs. Stephanie Kurti,
Elizabeth Edwards, and Jeremy Akers from James Madison University. To participate, you must
be in good health and not diagnosed with any cardiovascular, pulmonary, or metabolic
diseases. The purpose of this study is to determine whether varying fatty acid composition
impacts how the airways respond to a single high fat meal. Previous research tells us that this
inflammatory response is associated with asthma development, particularly if inflammation
remains elevated chronically. Therefore we aim to determine whether varying the fatty acid
composition of the smoothie can alter the airway inflammatory response to a single high-fat
meal. This study will contribute to the knowledge of both practitioners and clinicians, and may
provide an important public health message in providing dietary recommendations for those
with elevated airway inflammation, particularly asthma. Should you decide to participate in
this research study, you will be asked to sign this consent form once all your questions have
been answered to your satisfaction.
Research Procedures
This study consists of a questionnaire, a dietary recall log, a body composition scan, and three
high-fat smoothie sessions administered to individual participants in the Human Performance
Laboratory at James Madison University. The total time required for participation in the
research study is outlined on the following page (time required section). The specific
procedures during each visit are included here:
Initial visit: On the first visit to the laboratory, you will be briefed on the study and asked to
complete the international physical activity questionnaire. You will also be advised how to
accurately complete a 4-day food intake record. If you’d like to see any of these
questionnaires prior to consenting, please ask a researcher and we’ll be happy to provide one
for you.
After completion of the questionnaire, we’ll assess your height and weight, and then
perform a DEXA scan to assess your body composition scan (how much of your body is
fat vs. lean mass). You will then begin the high-fat meal session that you were
randomized to.
Meal testing sessions (3 total): Your HFM testing sessions will be after a 10 hour fast. We will
do a baseline finger-stick to assess blood lipids and glucose. You will be asked to perform
several experimental measurements prior to consumption of a single high-fat meal (peach,
blueberry, or strawberry smoothie). Some of the meals may contain dairy and gluten. These
same measurements will be performed at baseline (0), 2, and 4 hours post-HFM. These include
the following: Pulmonary function testing, exhaled nitric oxide, finger-sticks for glucose and
triglycerides.
Time Required
Participation in this study will require ~19-20 hours your time over the course of 4 separate
visits. Upon completion of the study, you will receive all of your data. The visits are outlined
below:
Baseline Testing: On the first visit to the laboratory, you will complete the required
questionnaire, be advised on how to complete the food log, and undergo the body
composition scan, This will take approximately an hour.
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HFM Sessions: The three remaining HFM sessions will each be ~6 hours in length.
During this time, finger-sticks will be performed before, at 2, and 4 hours after the
HFM to assess triglycerides and glucose. Exhaled nitric oxide will be measured for
assessment of airway inflammation and pulmonary function tests will be done to
assess lung function. These tests will also take place at baseline (0), 2, and 4 hours
post-HFM.
Risks
Participation in this study does have some risks, although they are small. The risk of any
serious event during this study is very small. Possible risks include:
Finger sticks: You may experience discomfort and bruising after the finger-stick.
High fat meal: The high-fat meal protocol is of very short duration, and any changes in
blood lipids and glucose are unlikely to create any long-term health problems.
Additionally, this meal is not out of line with meals consumed on a regular basis by a
significant portion of the US population.
DEXA: The DEXA scan entails a low dose of radiation equivalent to approximately one
transatlantic flight (0.015 mSv= milliseievert). While there is no validated
questionnaire to define extensive exposure, radiation exposure is cumulative (200
DEXA scans is equal to the cumulative exposure of living at sea level for a year (3
mSv). DEXA scans carry minimal X-ray exposure. To minimize exposure, the DEXA scan
will only be performed once. All body composition assessment will be performed
according to the American College of Sports Medicine guidelines for body composition
assessment).
Benefits
By participating in this study, you will learn about your current metabolic health (blood lipids
and glucose), body composition, chronic diet, weekly physical activity, and lung function
values. Your data will be provided to you upon completion of your participation in the study. If
an emergency arises and you must dropout, you may still receive your data. Having these tests
done in a lab would cost several hundreds of dollars.
Society may benefit from more knowledge about how various fatty acid composition impacts
the airway inflammatory response to a high fat meal, which is associated with respiratory
disease development (i.e. asthma). Additionally, society will learn whether lifestyle (chronic
diet and exercise) may attenuate these deleterious postprandial responses.
Confidentiality
The results of this research will be presented at the American College of Sports Medicine
Annual meeting as well as the American Society of Nutrition annual conferences. The results of
this project will be coded in such a way that the respondent’s identity will not be attached to
the final form of this study. The researcher retains the right to use and publish non-identifiable
data. While individual responses are confidential, aggregate data will be presented
representing averages or generalizations about the responses as a whole. All data will be
stored in a secure location accessible only to the JMU researchers. Upon completion of the
study, all information that matches up individual respondents with their answers will be
destroyed.
Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate. Should you
choose to participate, you can withdraw at any time without consequences of any kind.
Questions about the Study
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If you have questions or concerns during the time of your participation in this study, or after its
completion or you would like to receive a copy of the final aggregate results of this study,
please contact:
Researcher’s Name: Dr. Stephanie Kurti
Email Address: kurtisp@jmu.edu

Department of Kinesiology
James Madison University

Cell-Phone number: 630-205-6363
Telephone: 540-568-3947
Researcher’s Name: Dr. Elizabeth Edwards
E-mail Address: edwardes@jmu.edu

Department of Kinesiology
James Madison University

Telephone: 540-568-5220
Researcher’s Name: Dr. Jeremy Akers
Email Address: akersjd@jmu.edu
Telephone: 540-568-8974

Department of Health Professions
James Madison University

Researcher’s Name: Breanna Davidson
Email Address: davidsbl@dukes.jmu.edu
Telephone: 540-568-3952

Department of Kinesiology
James Madison University

Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu
Giving of Consent
I have read this consent form and I understand what is being requested of me as a participant
in this study. I freely consent to participate. I have been given satisfactory answers to my
questions. The investigator provided me with a copy of this form. I certify that I am at least 18
years of age.
______________________________________
Name of Participant (Printed)
______________________________________ ______________
Name of Participant (Signed)
Date
______________________________________ ______________
Name of Researcher (Signed)
Date
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ID _________ AC ___________ m0

Activity Monitor Log
As a participant in this program, we ask that you wear your Activity Monitor for one
week. Begin wearing the monitor on the Requested Start Date. Please try to wear the
monitor for seven consecutive days, but if you do need to skip a day for any reason,
continue wearing it until you have worn it for a full seven days.
Requested Start Date:
Requested End Date:

/
/

/ 18
/ 18

When you get up in the morning
When you go to bed at night

Please record the actual dates/times you wore the accelerometer in the table below. Please
be as precise as possible in reporting the times you put on and removed the monitor.

Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

Date
Time of day you put
on the unit
Time of day you took
off the unit
Any time you did not
wear the unit?
(e.g. naps, bathing)
Please provide comments about problems that occurred while you were wearing the unit.
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE
We are interested in finding out about the kinds of physical activities that people do as
part of their everyday lives. The questions will ask you about the time you spent being
physically active in the last 7 days. Please answer each question even if you do not
consider yourself to be an active person. Please think about the activities you do at work,
as part of your house and yard work, to get from place to place, and in your spare time for
recreation, exercise or sport.
Think about all the vigorous and moderate activities that you did in the last 7 days.
Vigorous physical activities refer to activities that take hard physical effort and make you
breathe much harder than normal. Moderate activities refer to activities that take
moderate physical effort and make you breathe somewhat harder than normal.
PART 1: JOB-RELATED PHYSICAL ACTIVITY
The first section is about your work. This includes paid jobs, farming, volunteer work,
course work, and any other unpaid work that you did outside your home. Do not include
unpaid work you might do around your home, like housework, yard work, general
maintenance, and caring for your family. These are asked in Part 3.
1.

Do you currently have a job or do any unpaid work outside your home?
Yes
No

Skip to PART 2: TRANSPORTATION

The next questions are about all the physical activity you did in the last 7 days as part of
your paid or unpaid work. This does not include traveling to and from work.
2.
During the last 7 days, on how many days did you do vigorous physical
activities like heavy lifting, digging, heavy construction, or climbing up stairs as
part of your work? Think about only those physical activities that you did for at
least 10 minutes at a time.
_____ days per week
No vigorous job-related physical activity
3.

Skip to question 4

How much time did you usually spend on one of those days doing vigorous
physical activities as part of your work?
_____ hours per day
_____ minutes per day

4.

Again, think about only those physical activities that you did for at least 10
minutes at a time. During the last 7 days, on how many days did you do
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moderate physical activities like carrying light loads as part of your work?
Please do not include walking.
_____ days per week
No moderate job-related physical activity
5.

Skip to question 6

How much time did you usually spend on one of those days doing moderate
physical activities as part of your work?
_____ hours per day
_____ minutes per day

6.

During the last 7 days, on how many days did you walk for at least 10 minutes at
a time as part of your work? Please do not count any walking you did to travel
to or from work.
_____ days per week
No job-related walking

7.

Skip to PART 2: TRANSPORTATION

How much time did you usually spend on one of those days walking as part of
your work?
_____ hours per day
_____ minutes per day

PART 2: TRANSPORTATION PHYSICAL ACTIVITY
These questions are about how you traveled from place to place, including to places like
work, stores, movies, and so on.
8.

During the last 7 days, on how many days did you travel in a motor vehicle like
a train, bus, car, or tram?
_____ days per week
No traveling in a motor vehicle

9.

Skip to question 10

How much time did you usually spend on one of those days traveling in a train,
bus, car, tram, or other kind of motor vehicle?
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_____ hours per day
_____ minutes per day
Now think only about the bicycling and walking you might have done to travel to and
from work, to do errands, or to go from place to place.
10.

During the last 7 days, on how many days did you bicycle for at least 10 minutes
at a time to go from place to place?
_____ days per week
No bicycling from place to place

Skip to question 12
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11.

How much time did you usually spend on one of those days to bicycle from place
to place?
_____ hours per day
_____ minutes per day

12.

During the last 7 days, on how many days did you walk for at least 10 minutes at
a time to go from place to place?
_____ days per week
No walking from place to place

13.

Skip to PART 3:
HOUSEWORK, HOUSE
MAINTENANCE, AND
CARING FOR FAMILY

How much time did you usually spend on one of those days walking from place
to place?
_____ hours per day
_____ minutes per day

PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY
This section is about some of the physical activities you might have done in the last 7
days in and around your home, like housework, gardening, yard work, general
maintenance work, and caring for your family.
14.

Think about only those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do vigorous physical
activities like heavy lifting, chopping wood, shoveling snow, or digging in the
garden or yard?
_____ days per week
No vigorous activity in garden or yard

15.

Skip to question 16

How much time did you usually spend on one of those days doing vigorous
physical activities in the garden or yard?
_____ hours per day
_____ minutes per day
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16.

Again, think about only those physical activities that you did for at least 10
minutes at a time. During the last 7 days, on how many days did you do
moderate activities like carrying light loads, sweeping, washing windows, and
raking in the garden or yard?
_____ days per week
No moderate activity in garden or yard

17.

Skip to question 18

How much time did you usually spend on one of those days doing moderate
physical activities in the garden or yard?
_____ hours per day
_____ minutes per day

18.

Once again, think about only those physical activities that you did for at least 10
minutes at a time. During the last 7 days, on how many days did you do
moderate activities like carrying light loads, washing windows, scrubbing floors
and sweeping inside your home?
_____ days per week
No moderate activity inside home

19.

Skip to PART 4:
RECREATION, SPORT
AND LEISURE-TIME
PHYSICAL ACTIVITY

How much time did you usually spend on one of those days doing moderate
physical activities inside your home?
_____ hours per day
_____ minutes per day

PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY
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This section is about all the physical activities that you did in the last 7 days solely for
recreation, sport, exercise or leisure. Please do not include any activities you have already
mentioned.
20.

Not counting any walking you have already mentioned, during the last 7 days, on
how many days did you walk for at least 10 minutes at a time in your leisure
time?
_____ days per week
No walking in leisure time

21.

Skip to question 22

How much time did you usually spend on one of those days walking in your
leisure time?
_____ hours per day
_____ minutes per day

22.

Think about only those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do vigorous physical
activities like aerobics, running, fast bicycling, or fast swimming in your leisure
time?
_____ days per week
No vigorous activity in leisure time

23.

Skip to question 24

How much time did you usually spend on one of those days doing vigorous
physical activities in your leisure time?
_____ hours per day
_____ minutes per day

24.

Again, think about only those physical activities that you did for at least 10
minutes at a time. During the last 7 days, on how many days did you do
moderate physical activities like bicycling at a regular pace, swimming at a
regular pace, and doubles tennis in your leisure time?
_____ days per week
No moderate activity in leisure time

25.

Skip to PART 5: TIME
SPENT SITTING

How much time did you usually spend on one of those days doing moderate
physical activities in your leisure time?
_____ hours per day
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_____ minutes per day

PART 5: TIME SPENT SITTING
The last questions are about the time you spend sitting while at work, at home, while
doing course work and during leisure time. This may include time spent sitting at a desk,
visiting friends, reading or sitting or lying down to watch television. Do not include any
time spent sitting in a motor vehicle that you have already told me about.
26.

During the last 7 days, how much time did you usually spend sitting on a
weekday?
_____ hours per day
_____ minutes per day

27.

During the last 7 days, how much time did you usually spend sitting on a
weekend day?
_____ hours per day
_____ minutes per day

This is the end of the questionnaire, thank you for participating.
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